Case Reports
23 June 2016
Vol. 10 No. 2 (2016)
https://doi.org/10.4081/itjm.2016.618

Myocardial contrast echocardiography in the diagnosis of a left ventricular hemangioma

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Contrast echocardiography, myocardial microcirculation, hemangioma, heart neoplasms, left ventricle, hypervascular tumor.
1619
Views
1751
Downloads
518
HTML

Authors

Kyriacos Papadopoulos
kyriacospap@hotmail.com
Medical Check-Up Center, Nicosia, Cyprus.
Constantinos Makrides
General Practitioner, Limassol, Cyprus.
Myocardial perfusion contrast echocardiography is an imaging tool for the assessment of myocardial microcirculation. It can also be used for the evaluation of the relative perfusion of a cardiac mass. Cardiac hemangiomas are rare tumors, accounting for only 2.8% of all benign primary cardiac tumors. We report a case of a 17-year-old man with a left ventricular hemangioma detected with transthoracic echocardiography. Myocardial perfusion contrast echocardiography was used to evaluate the vascularity of the cardiac mass. Using this technique malignant and hypervascular (e.g., hemangioma) tumors display persistence of contrast enhancement compared to the surrounding myocardium. The mass was successfully removed and the final report from pathology showed that the left ventricular mass was a hemangioma, a hypervascular tumor

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



Myocardial contrast echocardiography in the diagnosis of a left ventricular hemangioma. (2016). Italian Journal of Medicine, 10(2), 151-153. https://doi.org/10.4081/itjm.2016.618

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.